ACEP Nowcast host Amy Faith Ho, MD, MPH, FACEP, speaks with Associate Editor Catherine Marco, MD, FACEP, about her article on Xylazine the ‘Zombie Drug’ and its effects on patients who present with this rare and complicated issue. Plus, a quick recap on this month’s issue.
Read more on ACEPNow.com
Revisit ACEP Nowcast podcast episodes.
Catch up on all of ACEP Now in past issues.
No Responses to “July 2023: Xylazine the“Zombie Drug” is an Emerging Threat plus Issue Recap”